Dividend companies are always interesting for investors looking for passive income. But it's even better when the share price of the company itself rises along with the dividend. Today, we'll look at 2 that analysts believe have just that potential.
AbbVie $ABBV
AbbVie is a pharmaceutical company with a strong brand and reputation, particularly in the area of drugs for immune diseases and gastroenterology. Its largest drug , Humira, for the treatment of rheumatoid arthritis and Crohn's disease, generates nearly half of its revenue.
In terms of growth, AbbVie faces near-term challenges in the form of the loss of its patent on Humira, which expires in the U.S. in 2023. The company is therefore aggressively expanding its drug portfolio through acquisition and has a pipeline of new drugs in development, particularly in the areas of neuroscience, oncology and immunology. The flagship drugs in the portfolio include Skyrizi, Rinvoq and Imbruvica. With their help and other new drugs, it has the…
May I ask on what basis is it estimated that ABBV will have a problem paying/increasing dividends? TTM EPS 10.97, 2024 EPS is estimated at 11.07, current dividend is 5.92usd, with approx 5-8% increase the payout ratio will be approx 57%
Interesting company! Thank you very much.🙏
I didn't know$MPX, but Abbvie an obvious choice ♥️